One of pharma's most notorious gougers is going bankrupt, but 2019 is a banner year for shkreli-grade pharmaceutical price-hikes

Manufacturers of popular generics are causing problems with a variety of medications, all to boost profits and renegotiate/manipulate rates with insurers. I’ve read articles speculating that there are industry-wide fears of another Amazon disruption:

https://www.bloomberg.com/news/articles/2018-04-11/are-drug-prices-too-low

4 Likes